Adage Capital Partners Gp, L.L.C. Bio Rad Laboratories, Inc. Transaction History

Adage Capital Partners Gp, L.L.C.

$54.6 Billion
Q3 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$268.26 - $339.48 $241,434 - $305,532	-900 Reduced 4.39%	19,610 $5.36 Million
Q1 2024 May 15, 2024	BUY	$304.11 - $351.99 $60,822 - $70,398	200 Added 0.98%	20,510 $7.09 Million
Q4 2023 Feb 14, 2024	BUY	$269.37 - $365.04 $5.25 Million - $7.12 Million	19,500 Added 2407.41%	20,310 $6.56 Million
Q3 2023 Nov 14, 2023	SELL	$350.25 - $422.63 $7.18 Million - $8.66 Million	-20,500 Reduced 96.2%	810 $290,000
Q2 2023 Aug 14, 2023	SELL	$359.49 - $486.4 $3.51 Million - $4.75 Million	-9,765 Reduced 31.42%	21,310 $8.08 Million
Q1 2023 May 15, 2023	SELL	$418.69 - $503.0 $167,476 - $201,200	-400 Reduced 1.27%	31,075 $14.9 Million
Q4 2022 Feb 14, 2023	SELL	$351.71 - $456.01 $14 Million - $18.2 Million	-39,900 Reduced 55.9%	31,475 $13.2 Million
Q3 2022 Nov 14, 2022	SELL	$412.59 - $563.26 $12.7 Million - $17.3 Million	-30,700 Reduced 30.08%	71,375 $29.8 Million
Q2 2022 Aug 15, 2022	BUY	$463.67 - $597.16 $16.2 Million - $20.8 Million	34,900 Added 51.95%	102,075 $50.5 Million
Q1 2022 May 16, 2022	BUY	$524.57 - $735.42 $23.2 Million - $32.5 Million	44,165 Added 191.94%	67,175 $37.8 Million
Q4 2021 Feb 14, 2022	SELL	$708.84 - $794.68 $70,884 - $79,468	-100 Reduced 0.43%	23,010 $17.4 Million
Q3 2021 Nov 15, 2021	SELL	$657.71 - $825.77 $197,313 - $247,731	-300 Reduced 1.28%	23,110 $17.2 Million
Q2 2021 Aug 16, 2021	SELL	$576.64 - $649.04 $121,094 - $136,298	-210 Reduced 0.89%	23,410 $15.1 Million
Q1 2021 May 17, 2021	BUY	$547.01 - $662.35 $125,812 - $152,340	230 Added 0.98%	23,620 $13.5 Million
Q4 2020 Feb 16, 2021	SELL	$510.68 - $643.45 $311,514 - $392,504	-610 Reduced 2.54%	23,390 $13.6 Million
Q3 2020 Nov 16, 2020	BUY	$454.43 - $535.6 $8.27 Million - $9.75 Million	18,200 Added 313.79%	24,000 $12.4 Million
Q2 2020 Aug 14, 2020	BUY	$334.87 - $493.06 $1.94 Million - $2.86 Million	5,800 New	5,800 $2.62 Million
Q4 2018 Feb 14, 2019	SELL	$220.1 - $309.0 $19.8 Million - $27.8 Million	-90,000 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$289.28 - $326.15 $2.89 Million - $3.26 Million	10,000 Added 12.5%	90,000 $28.2 Million
Q2 2018 Aug 14, 2018	BUY	$244.1 - $303.88 $1.22 Million - $1.52 Million	5,000 Added 6.67%	80,000 $23.1 Million
Q1 2018 May 15, 2018	SELL	$233.97 - $274.11 $4.33 Million - $5.07 Million	-18,500 Reduced 19.79%	75,000 $18.8 Million
Q4 2017 Feb 14, 2018	SELL	$216.94 - $271.3 $1.41 Million - $1.76 Million	-6,500 Reduced 6.5%	93,500 $22.3 Million
Q3 2017 Nov 14, 2017	BUY	$212.27 - $242.28 $21.2 Million - $24.2 Million	100,000	100,000 $22.2 Million

Others Institutions Holding BIO

# of Institutions

457

Shares Held

18.2M

Call Options Held

19.5K

Put Options Held

13.9K

View Full List

About BIO-RAD LABORATORIES, INC.

Ticker BIO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 24,633,900
Market Cap $8.37B
Description
Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...

More about BIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Adage Capital Partners Gp, L.L.C., based on Form 13F filings with the SEC.

News

Stay updated on Adage Capital Partners Gp, L.L.C. with notifications on news.

Account